Louisiana 2015 2015 Regular Session

Louisiana House Bill HB174 Comm Sub / Analysis

                    DIGEST
The digest printed below was prepared by House Legislative Services.  It constitutes no part of the
legislative instrument.  The keyword, one-liner, abstract, and digest do not constitute part of the law
or proof or indicia of legislative intent.  [R.S. 1:13(B) and 24:177(E)]
HB 174 Reengrossed 2015 Regular Session	LeBas
Abstract: Adds certain substances to Schedules I and IV.
Present law provides for the designation of controlled dangerous substances into Schedules I, II, III,
IV, and V based upon the substances' potential for addiction and abuse.
Proposed law adds two substances to Schedule IV.
Present law provides that hydrocodone is a Schedule II drug, but is a Schedule III drug when found
in combination with other substances.
Proposed law repeals the Schedule III classification for hydrocodone combination products to make
La. law consistent with federal scheduling classifications.
(Adds R.S. 40:964(Schedule IV)(A)(3) and (B)(45.5); Repeals R.S. 40:964(Schedule III)(D)(1)(c)
and (d))
Effective upon signature of governor or lapse of time for gubernatorial action. Summary of Amendments Adopted by House
The Committee Amendments Proposed by House Committee on Administration of Criminal
Justice to the original bill:
1. Add emergency effective date.
2.  Provide penalties for violations involving Mitragynine and 7-Hydroxy-mitragynine.
The House Floor Amendments to the engrossed bill:
1. Remove the proposed law addition of Mitragynine and 7-Hydroxy-mitragynine into
Schedule I and removes penalty provisions for violations involving those substances.